omniture
北京引正生物科技有限公司

Latest News

GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

* Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipi...

2025-11-24 08:00 1189

GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies

HONG KONG, Sept. 30, 2024 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a biotech company co-f...

2024-09-30 19:36 2896